Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMIPENEM vs INAVOLISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IMIPENEM vs INAVOLISIB: Safety Overview

Metric IMIPENEM INAVOLISIB
Total FAERS Reports 1,879 188
Deaths Reported 604 6
Death Rate 32.1% 3.2%
Hospitalizations 826 60
Average Patient Age 50.1 yrs 62.1 yrs
% Female Patients 40.5% 99.4%
FDA Approval Date N/A Oct 10, 2024
Manufacturer N/A Genentech, Inc.
Route N/A ORAL
Marketing Status N/A Prescription